SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-12-319811
Filing Date
2012-07-27
Accepted
2012-07-27 17:21:05
Documents
3
Group Members
B & R ACQUISITION CO

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE TO d386856dsctota.htm SC TO-T/A 43108
2 PRESS RELEASE ISSUED BY BRISTOL-MYERS SQUIBB COMPANY, DATED JULY 26, 2012 d386856dex99a5m.htm EX-99.(A)(5)(M) 9390
3 GRAPHIC g386856g38w72.jpg GRAPHIC 12648
  Complete submission text file 0001193125-12-319811.txt   71740
Mailing Address 345 PARK AVE NEW YORK NY 10154
Business Address 345 PARK AVE NEW YORK NY 10154 2125464000
BRISTOL MYERS SQUIBB CO (Filed by) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Subject) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-42168 | Film No.: 12991438
SIC: 2834 Pharmaceutical Preparations